DB05457InvestigationalSmall molecule
OSI-7904L is a liposome encapsulated thymidylate synthase inhibitor, which is indicated for use in advanced gastric and/or gastroesophageal adenocarcinoma (A-G/GEJA). Current treatments also inhibit thymidylate synthase but the innovative lipid...
- Mechanism
- Curator reviewed
Inhibits thymidylate synthase.
- Primary indication
- Investigated for use/treatment in gastric cancer.Curator reviewed
- Code names
- OSI-7904L
Resolves to
Compound
Targets
What you can answer from here — as of April 02, 2025
Which drugs share a target with OSI-7904L, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account